Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Curaleaf Holdings, Inc.
  6. Company
    CURA   CA23126M1023

CURALEAF HOLDINGS, INC.

(CURA)
  Report
Delayed CANADIAN NATIONAL STOCK EXCHANGE  -  03:59 2022-09-28 pm EDT
7.000 CAD   +1.89%
09/20Curaleaf : NOTICE OF ISSUANCE OR PROPOSED ISSUANCE OF LISTED SECURITIES - Form 6-K
PU
09/19Curaleaf Holdings Closes Purchase of Majority Stake in Germany's Four 20 Pharma; Opens Allentown, Pa., Dispensary
MT
09/19Curaleaf Celebrates Opening of Allentown, Pennsylvania Dispensary
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. is a Canada-based international provider of consumer products in the cannabis market. The Company improves lives by providing cannabis for consumption. The Company and its brands, including Curaleaf and Select, provide service, product selection and accessibility across the medical and adult-use markets. The Company operates in 22 states with 133 dispensaries and 26 cultivation sites. It focuses on populated, limited license states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. Curaleaf International is the vertically integrated cannabis company in Europe with a supply and distribution network throughout the European market, bringing together science and research with cultivation, extraction and production. The Company's brands also include Curaleaf Hemp, UKU Cannabis and Grassroots. Curaleaf is a national retail dispensary brand in the United States, which is available in multiple states and product formats.
Sales per Business
20202021Delta
Cannabis786.3093.6%1 513.6999.8% +92.51%
Non-Cannabis54.216.4%2.900.2% -94.64%
CAD in Million
Sales per region
20202021Delta
United States840.51100%1 516.59100% +80.44%
CAD in Million
Managers
Name Title Age Since
Matt Darin President & Chief Executive Officer - 2022
Edward Kremer Chief Financial Officer - 2022
Robert Winnicki Senior VP-Research & Product Development - 2015
James Shorris Chief Compliance Officer 60 2020
Camilo Lyon Chief Investment Officer - 2022
Carlos Madrazo Villaseñor Senior VP-Investor Relations & Capital Markets - 2021
Eduard Kelenchuk Senior Vice President-Business Development - -
Keisha Brice Vice President - -
Talley Wettlaufer Senior Vice President-Retail - 2020
Antonio Costanzo Chief Executive Officer-International - 2021
Members of the board
Name Title Age Since
Boris Jordan Executive Chairman 55 2013
Karl Johansson Independent Director 71 2018
Peter Derby Independent Director 60 2018
Jaswinder Grover, Dr. Independent Director 55 2020
Joseph Lusardi Executive Vice Chairman 47 2021
Mitchell Kahn Director 60 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 616,165,716 413,556,070 67.1% 0 0.0% 58.2%
Stock B 0 93,970,705 0 0.0% 0 0.0%
Shareholders
NameEquities%
Andrei Blokh 127,896,211 20.8%
Boris Jordan 56,643,112 9.21%
Jaswinder Grover 5,468,378 0.89%
Joseph Lusardi 5,353,263 0.87%
Mitchell Kahn 4,606,979 0.75%
Matt Darin 3,180,837 0.52%
Scopus Asset Management LP 1,550,000 0.25%
Fidelity Investments Canada ULC 1,157,214 0.19%
Chiron Investment Management LLC 635,808 0.10%
Peter Clateman 604,142 0.098%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Curaleaf Holdings, Inc.
Sector Pharmaceuticals
1st jan.Capi. (M$)
CURALEAF HOLDINGS, INC.-38.05%3 632
JOHNSON & JOHNSON-2.75%437 390
ELI LILLY AND COMPANY12.63%317 719
ROCHE HOLDING AG-17.54%273 173
ABBVIE INC.4.67%255 667
PFIZER, INC.-24.76%249 357
NOVO NORDISK A/S1.63%224 155
MERCK & CO., INC.13.23%219 838
ASTRAZENECA PLC16.11%167 902
NOVARTIS AG-7.34%166 661
BRISTOL-MYERS SQUIBB COMPANY15.57%153 866
AMGEN INC.2.67%123 558
SANOFI-11.14%95 184
CSL LIMITED-2.09%88 263
ZOETIS-37.61%71 279
MERCK KGAA-28.39%68 152
GSK PLC-18.37%58 409
DAIICHI SANKYO CO., LTD.36.65%52 304
BAYER AG2.53%45 654
BIOGEN INC.15.29%40 140
TAKEDA PHARMACEUTICAL COMPANY LIMITED19.48%39 954
Connections : Curaleaf Holdings, Inc.